Biomarkers for clinical outcome among patients with advanced or metastatic NSCLC treated with pembrolizumab alone or in combination with chemotherapy

被引：0
|
作者：
Abed, Afaf [1 ,2 ,3 ]
Beasley, Aaron [1 ,2 ]
Reid, Anna [1 ,2 ]
Law, Nc [4 ]
Leslie, Calapre [1 ,2 ]
Michael, Millward [3 ]
Johnny, Lo [1 ]
Elin, Gray [1 ,2 ]
机构：
[1] Edith Cowan Univ, Sch Sci, Joondalup, Australia
[2] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, Australia
[3] Univ Western Australia, Sch Med, Crawley, Australia
[4] Sir Charles Gairdner Hosp, Dept Med Oncol, Nedlands, WA, Australia
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
34
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [31] Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407
    Cheng, Ying
    Zhang, Li
    Hu, Jie
    Wang, Donglin
    Hu, Chengping
    Zhou, Jianying
    Wu, Lin
    Cao, Lejie
    Liu, Jiwei
    Zhang, Helong
    Sun, Hong
    Wang, Ziping
    Gao, Hongjun
    Sun, Yuping
    Li, Ben
    Hu, Xiaohan
    Schwarzenberger, Paul
    Paz-Ares, Luis
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (10):
  • [32] Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy
    Abed, A.
    Beasley, A. B.
    Reid, A. L.
    Law, N.
    Calapre, L.
    Millward, M.
    Lo, J.
    Gray, E. S.
    ESMO OPEN, 2023, 8 (06)
  • [33] Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome
    Harmon, Charles S.
    DePrimo, Sam E.
    Socinski, Mark
    Scagliotti, Giorgio
    Rosell, Rafael
    Govindan, Ramaswamy
    Page, Ray D.
    Hainsworth, John
    Brahmer, Julie R.
    Blais, Normand
    Novello, Silvia
    Tye, Lesley
    Kim, Sindy
    Williams, James A.
    Chao, Richard
    CANCER RESEARCH, 2010, 70
  • [34] Phase III clinical trials in chemotherapy-naive patients with advanced NSCLC assessing the combination of atezolizumab and chemotherapy
    Reck, M.
    Papadimitrakopoulou, V. A.
    Cappuzzo, F.
    Jotte, R.
    Mok, T. S. K.
    Sandler, A.
    Waterkamp, D.
    Coleman, S.
    Asakawa, T.
    Socinski, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy
    Zhou, Caicun
    Wang, Yina
    Zhao, Jun
    Chen, Gongyan
    Liu, Zhihua
    Gu, Kangsheng
    Huang, Meijuan
    He, Jianxing
    Chen, Jianhua
    Ma, Zhiyong
    Feng, Jifeng
    Shi, Jianhua
    Yu, Xinmin
    Cheng, Ying
    Yao, Yu
    Chen, Yuan
    Guo, Renhua
    Lin, Xiaoyan
    Wang, Zhehai
    Gao, Guanghui
    Wang, Quanren
    Li, Weixia
    Yang, Xinfeng
    Wu, Lihong
    Zhang, Jun
    Ren, Shengxiang
    CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1296 - 1304
  • [36] The effect of LNS8801 alone and in combination with pembrolizumab in patients with metastatic uveal melanoma
    Shoushtari, Alexander Noor
    Chaney, Marya F.
    Cohen, Justine Vanessa
    Garyantes, Tina
    Lin, Jessica Jiyeong
    Ishizuka, Jeffrey Joseph
    Mita, Alain C.
    Mita, Monica M.
    Muller, Carolyn
    Natale, Christopher
    Orloff, Marlana M.
    Papadopoulos, Kyriakos P.
    Patel, Sapna Pradyuman
    Ahnert, Jordi Rodon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Randomized Phase II Study of Pembrolizumab after SBRT versus Pembrolizumab Alone in Patients with Advanced NSCLC, Preliminary Results
    Theelen, Willemijn
    Lalezari, Ferry
    Van Den Heuvel, Michel
    Baas, Paul
    Peulen, Heike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1453 - S1453
  • [38] Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study
    Chen, Ya
    Wang, Yanan
    Yang, Zhengyu
    Hu, Minjuan
    Zhang, Yanwei
    Qian, Fangfei
    Zhang, Wei
    Zhang, Bo
    Han, Baohui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel
    Meehan, Danielle
    Pang, Yan
    Fisher, Patricia
    Hatton, Matthew
    Mathew, Tony
    Lee, Caroline
    Das, Tathagata
    Young, Robin
    Bates, Emma
    Taylor, Fiona
    Abu, Faruk
    LUNG CANCER, 2023, 178 : S37 - S37
  • [40] Veliparib in combination with nivolumab and platinum doublet chemotherapy (CT) in metastatic/advanced NSCLC.
    Clarke, Jeffrey Melson
    Patel, Jyoti D.
    Robert, Francisco
    Kio, Ebenezer A.
    Thara, Eddie
    Garofalo, Brage
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345